These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


259 related items for PubMed ID: 26516304

  • 1. Serum Immune Proteins in Moderate and Severe Chronic Fatigue Syndrome/Myalgic Encephalomyelitis Patients.
    Hardcastle SL, Brenu EW, Johnston S, Nguyen T, Huth T, Ramos S, Staines D, Marshall-Gradisnik S.
    Int J Med Sci; 2015; 12(10):764-72. PubMed ID: 26516304
    [Abstract] [Full Text] [Related]

  • 2. Poor sleep quality is associated with greater circulating pro-inflammatory cytokines and severity and frequency of chronic fatigue syndrome/myalgic encephalomyelitis (CFS/ME) symptoms in women.
    Milrad SF, Hall DL, Jutagir DR, Lattie EG, Ironson GH, Wohlgemuth W, Nunez MV, Garcia L, Czaja SJ, Perdomo DM, Fletcher MA, Klimas N, Antoni MH.
    J Neuroimmunol; 2017 Feb 15; 303():43-50. PubMed ID: 28038892
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. The role of low-grade inflammation in ME/CFS (Myalgic Encephalomyelitis/Chronic Fatigue Syndrome) - associations with symptoms.
    Jonsjö MA, Olsson GL, Wicksell RK, Alving K, Holmström L, Andreasson A.
    Psychoneuroendocrinology; 2020 Mar 15; 113():104578. PubMed ID: 31901625
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Longitudinal analysis of immune abnormalities in varying severities of Chronic Fatigue Syndrome/Myalgic Encephalomyelitis patients.
    Hardcastle SL, Brenu EW, Johnston S, Nguyen T, Huth T, Ramos S, Staines D, Marshall-Gradisnik S.
    J Transl Med; 2015 Sep 14; 13():299. PubMed ID: 26370228
    [Abstract] [Full Text] [Related]

  • 7. Fecal metagenomic profiles in subgroups of patients with myalgic encephalomyelitis/chronic fatigue syndrome.
    Nagy-Szakal D, Williams BL, Mishra N, Che X, Lee B, Bateman L, Klimas NG, Komaroff AL, Levine S, Montoya JG, Peterson DL, Ramanan D, Jain K, Eddy ML, Hornig M, Lipkin WI.
    Microbiome; 2017 Apr 26; 5(1):44. PubMed ID: 28441964
    [Abstract] [Full Text] [Related]

  • 8. Novel characterisation of mast cell phenotypes from peripheral blood mononuclear cells in chronic fatigue syndrome/myalgic encephalomyelitis patients.
    Nguyen T, Johnston S, Chacko A, Gibson D, Cepon J, Smith P, Staines D, Marshall-Gradisnik S.
    Asian Pac J Allergy Immunol; 2017 Jun 26; 35(2):75-81. PubMed ID: 27362406
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Reductions in circulating levels of IL-16, IL-7 and VEGF-A in myalgic encephalomyelitis/chronic fatigue syndrome.
    Landi A, Broadhurst D, Vernon SD, Tyrrell DL, Houghton M.
    Cytokine; 2016 Feb 26; 78():27-36. PubMed ID: 26615570
    [Abstract] [Full Text] [Related]

  • 11. Cytokine signature associated with disease severity in chronic fatigue syndrome patients.
    Montoya JG, Holmes TH, Anderson JN, Maecker HT, Rosenberg-Hasson Y, Valencia IJ, Chu L, Younger JW, Tato CM, Davis MM.
    Proc Natl Acad Sci U S A; 2017 Aug 22; 114(34):E7150-E7158. PubMed ID: 28760971
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. A systematic review of cytokines in chronic fatigue syndrome/myalgic encephalomyelitis/systemic exertion intolerance disease (CFS/ME/SEID).
    Corbitt M, Eaton-Fitch N, Staines D, Cabanas H, Marshall-Gradisnik S.
    BMC Neurol; 2019 Aug 24; 19(1):207. PubMed ID: 31445522
    [Abstract] [Full Text] [Related]

  • 14. Immunological abnormalities as potential biomarkers in Chronic Fatigue Syndrome/Myalgic Encephalomyelitis.
    Brenu EW, van Driel ML, Staines DR, Ashton KJ, Ramos SB, Keane J, Klimas NG, Marshall-Gradisnik SM.
    J Transl Med; 2011 May 28; 9():81. PubMed ID: 21619669
    [Abstract] [Full Text] [Related]

  • 15. Cellular Immune Function in Myalgic Encephalomyelitis/Chronic Fatigue Syndrome (ME/CFS).
    Cliff JM, King EC, Lee JS, Sepúlveda N, Wolf AS, Kingdon C, Bowman E, Dockrell HM, Nacul L, Lacerda E, Riley EM.
    Front Immunol; 2019 May 28; 10():796. PubMed ID: 31057538
    [Abstract] [Full Text] [Related]

  • 16. In myalgic encephalomyelitis/chronic fatigue syndrome, increased autoimmune activity against 5-HT is associated with immuno-inflammatory pathways and bacterial translocation.
    Maes M, Ringel K, Kubera M, Anderson G, Morris G, Galecki P, Geffard M.
    J Affect Disord; 2013 Sep 05; 150(2):223-30. PubMed ID: 23664637
    [Abstract] [Full Text] [Related]

  • 17. Dysregulation of the Kynurenine Pathway, Cytokine Expression Pattern, and Proteomics Profile Link to Symptomology in Myalgic Encephalomyelitis/Chronic Fatigue Syndrome (ME/CFS).
    Kavyani B, Ahn SB, Missailidis D, Annesley SJ, Fisher PR, Schloeffel R, Guillemin GJ, Lovejoy DB, Heng B.
    Mol Neurobiol; 2024 Jul 05; 61(7):3771-3787. PubMed ID: 38015302
    [Abstract] [Full Text] [Related]

  • 18. Association between cytokines and psychiatric symptoms in chronic fatigue syndrome and healthy controls.
    Groven N, Fors EA, Iversen VC, White LR, Reitan SK.
    Nord J Psychiatry; 2018 Nov 05; 72(8):556-560. PubMed ID: 30063870
    [Abstract] [Full Text] [Related]

  • 19. Evidence for inflammation and activation of cell-mediated immunity in Myalgic Encephalomyelitis/Chronic Fatigue Syndrome (ME/CFS): increased interleukin-1, tumor necrosis factor-α, PMN-elastase, lysozyme and neopterin.
    Maes M, Twisk FN, Kubera M, Ringel K.
    J Affect Disord; 2012 Feb 05; 136(3):933-9. PubMed ID: 21975140
    [Abstract] [Full Text] [Related]

  • 20. Defining the prevalence and symptom burden of those with self-reported severe chronic fatigue syndrome/myalgic encephalomyelitis (CFS/ME): a two-phase community pilot study in the North East of England.
    Strassheim VJ, Sunnquist M, Jason LA, Newton JL.
    BMJ Open; 2018 Sep 19; 8(9):e020775. PubMed ID: 30232103
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 13.